DNase enhances photodynamic therapy against fluconazole-resistant Candida albicans biofilms.

This study evaluated the effectiveness of DNase I combined with antimicrobial photodynamic therapy, mediated by Photodithazine® and light-emitting diode light, against biofilms formed by a fluconazole-resistant Candida albicans strain (ATCC 96901) and two clinical isolates (R14 and R70). Biofilms were grown for 48 h and exposed to DNase for 5 min, followed by application of a photosensitizer (P) and light (L), either singly or combined (P+L+, P-L+, P+L-, P-L-, P-L-DNase, P+L+DNase, P+L-DNase, and P-L+DNase; n = 12). Biofilm analysis included quantification of extracellular matrix components (water-soluble and insoluble polysaccharides, proteins and extracellular DNA), and biomass (total and insoluble), as well as the enumeration of colony-forming units. The data were analyzed using three-way analysis of variance with Bonferroni's post hoc test. The DNase treatment combined with aPDT showed a reduction of 1.92, 1.65, and 1.29 log10 of cell viability compared with untreated controls for ATCC 96901, R14, and R70 strains, respectively. It also reduced extracellular matrix contents of water-soluble polysaccharides (36.3%) and extracellular DNA (72.3%), as well as insoluble biomass content (43.3%). The three strains showed similar behavior when treated with DNase, and the extracellular matrix components were affected, improving the effectiveness of antimicrobial photodynamic therapy. © 2022 Wiley Periodicals LLC.

Citation

César Augusto Abreu-Pereira, Marlise Inêz Klein, Carmélia Isabel Vitorino Lobo, Ana Luiza Gorayb Pereira, Cláudia Carolina Jordão, Ana Claudia Pavarina. DNase enhances photodynamic therapy against fluconazole-resistant Candida albicans biofilms. Oral diseases. 2023 May;29(4):1855-1867

Mesh Tags

Substances

PMID: 35133698

search → result